Pharma Journalist -

Elicio Therapeutics, a next generation immuno-oncology company, announced that it has closed its $33 million Series B financing. Proceeds from the financing will be used to advance…
Read More...

Lantheus Holdings, Inc., parent company of Lantheus Medical Imaging, Inc., a leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and…
Read More...

Cellular Biomedicine Group, a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today announced it…
Read More...

GlaxoSmithKline plc (GSK) and Innoviva, Inc. (INVA) announced the filing of a supplemental New Drug Application (sNDA) to the US Food and Drug Administration (FDA) seeking an additional…
Read More...

Xylyx Bio announced the development of substrates for anti-fibrotic drug discovery as the next stage of its pipeline of pre-clinical cell culture products. Through the development of…
Read More...

Thermo Fisher Scientific announced the expansion of its API manufacturing capabilities following the completion of its previously announced acquisition of an active pharmaceutical…
Read More...

Astellas Pharma Inc. announced that it will invest nearly $13 million into two innovation incubators operated by LabCentral, a premier United States-based laboratory facility for…
Read More...

Elligo Health Research, a healthcare-enabling research organization, has received a grant from the U.S. Food and Drug Administration (FDA) for a follow-on project to extend the value of…
Read More...

Cellectis and Lonza announced that the companies have entered into a manufacturing service agreement covering clinical manufacturing of Cellectis’ allogeneic UCART product candidates…
Read More...

SMi Reports: Registration is open for Europe’s only Parallel Trade conference and exhibition taking place in February 2020 in London. SMi is delighted to announce the highly…
Read More...